Summit is a biotechnology company that developed very rapidly and was listed on the AIM segment of the London Stock Exchange. Summit is focused on discovering and developing new drugs which are underpinned by the company’s two technology platforms carbohydrate chemistry and chemical genomics, to treat serious diseases with a high unmet medical need.